Accuray Gross Margin 2010-2024 | ARAY
Current and historical gross margin for Accuray (ARAY) over the last 10 years. The current gross profit margin for Accuray as of June 30, 2024 is %.
| Accuray Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-06-30 | $0.45B | $0.14B | 31.84% |
| 2024-03-31 | $0.43B | $0.14B | 33.02% |
| 2023-12-31 | $0.45B | $0.15B | 34.00% |
| 2023-09-30 | $0.46B | $0.16B | 34.95% |
| 2023-06-30 | $0.45B | $0.16B | 34.68% |
| 2023-03-31 | $0.44B | $0.16B | 36.45% |
| 2022-12-31 | $0.42B | $0.16B | 37.41% |
| 2022-09-30 | $0.42B | $0.16B | 37.32% |
| 2022-06-30 | $0.43B | $0.16B | 37.53% |
| 2022-03-31 | $0.43B | $0.16B | 37.67% |
| 2021-12-31 | $0.44B | $0.17B | 38.22% |
| 2021-09-30 | $0.42B | $0.17B | 39.47% |
| 2021-06-30 | $0.40B | $0.16B | 40.40% |
| 2021-03-31 | $0.38B | $0.16B | 41.05% |
| 2020-12-31 | $0.38B | $0.16B | 41.11% |
| 2020-09-30 | $0.38B | $0.15B | 40.11% |
| 2020-06-30 | $0.38B | $0.15B | 39.06% |
| 2020-03-31 | $0.41B | $0.16B | 38.42% |
| 2019-12-31 | $0.41B | $0.16B | 38.39% |
| 2019-09-30 | $0.41B | $0.16B | 38.11% |
| 2019-06-30 | $0.42B | $0.16B | 38.76% |
| 2019-03-31 | $0.42B | $0.16B | 39.52% |
| 2018-12-31 | $0.41B | $0.16B | 38.83% |
| 2018-09-30 | $0.41B | $0.16B | 39.27% |
| 2018-06-30 | $0.41B | $0.16B | 39.75% |
| 2018-03-31 | $0.40B | $0.16B | 38.71% |
| 2017-12-31 | $0.40B | $0.16B | 38.75% |
| 2017-09-30 | $0.39B | $0.15B | 37.89% |
| 2017-06-30 | $0.38B | $0.14B | 36.46% |
| 2017-03-31 | $0.37B | $0.13B | 36.51% |
| 2016-12-31 | $0.38B | $0.14B | 38.40% |
| 2016-09-30 | $0.40B | $0.16B | 39.39% |
| 2016-06-30 | $0.40B | $0.16B | 39.85% |
| 2016-03-31 | $0.41B | $0.16B | 39.90% |
| 2015-12-31 | $0.40B | $0.16B | 39.10% |
| 2015-09-30 | $0.39B | $0.15B | 38.92% |
| 2015-06-30 | $0.38B | $0.15B | 38.16% |
| 2015-03-31 | $0.38B | $0.14B | 37.63% |
| 2014-12-31 | $0.38B | $0.14B | 37.99% |
| 2014-09-30 | $0.38B | $0.14B | 38.40% |
| 2014-06-30 | $0.37B | $0.14B | 38.38% |
| 2014-03-31 | $0.35B | $0.13B | 37.11% |
| 2013-12-31 | $0.33B | $0.11B | 33.94% |
| 2013-09-30 | $0.31B | $0.10B | 32.15% |
| 2013-06-30 | $0.32B | $0.10B | 30.91% |
| 2013-03-31 | $0.33B | $0.11B | 32.13% |
| 2012-12-31 | $0.36B | $0.12B | 33.79% |
| 2012-09-30 | $0.39B | $0.14B | 34.69% |
| 2012-06-30 | $0.41B | $0.14B | 33.25% |
| 2012-03-31 | $0.38B | $0.13B | 34.46% |
| 2011-12-31 | $0.34B | $0.12B | 36.61% |
| 2011-09-30 | $0.28B | $0.11B | 39.44% |
| 2011-06-30 | $0.22B | $0.11B | 47.75% |
| 2011-03-31 | $0.21B | $0.11B | 50.24% |
| 2010-12-31 | $0.21B | $0.10B | 50.00% |
| 2010-09-30 | $0.21B | $0.10B | 47.85% |
| 2010-06-30 | $0.22B | $0.10B | 46.85% |
| 2010-03-31 | $0.22B | $0.10B | 45.66% |
| 2009-12-31 | $0.23B | $0.11B | 46.05% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.204B | $0.447B |
| Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing ongoing services and upgrades to customers following installation of the CyberKnife System. Product revenues include sales of linacs for other uses. It also offers optional hardware and software, technical enhancements and upgrades to the CyberKnife & TomoTherapy System. The CyberKnife Systems include: the CyberKnife G4, CyberKnife VSI System and the new CyberKnife M6 Series System. TomoTherapy Systems include the Hi-Art System, delivering CT-guided, helical intensity modulated radiation therapy; the TomoHD System and the Tomo H Series Systems. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $214.078B | 26.12 |
| Intuitive Surgical (ISRG) | United States | $183.628B | 96.01 |
| Alcon (ALC) | Switzerland | $45.117B | 31.76 |
| IQVIA Holdings (IQV) | United States | $40.157B | 22.12 |
| Edwards Lifesciences (EW) | United States | $39.608B | 24.62 |
| IDEXX Laboratories (IDXX) | United States | $34.672B | 40.83 |
| DexCom (DXCM) | United States | $26.799B | 40.36 |
| Waters (WAT) | United States | $22.960B | 33.95 |
| STERIS (STE) | Ireland | $22.437B | 25.85 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.922B | 0.00 |
| Hologic (HOLX) | United States | $18.696B | 19.73 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.376B | 12.70 |
| Sysmex ADR (SSMXY) | Japan | $11.851B | 37.16 |
| Globus Medical (GMED) | United States | $11.200B | 28.52 |
| Teleflex (TFX) | United States | $9.378B | 14.96 |
| Penumbra (PEN) | United States | $8.969B | 87.86 |
| Masimo (MASI) | United States | $8.917B | 43.43 |
| Glaukos (GKOS) | United States | $7.755B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.126B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.542B | 25.75 |
| Inari Medical (NARI) | United States | $3.119B | 0.00 |
| TransMedics (TMDX) | United States | $2.898B | 91.86 |
| LivaNova (LIVN) | United Kingdom | $2.829B | 16.33 |
| Veracyte (VCYT) | United States | $2.811B | 85.09 |
| Nihon Kohden (NHNKY) | Japan | $2.519B | 15.68 |
| Tandem Diabetes Care (TNDM) | United States | $2.242B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.227B | 18.14 |
| Integra LifeSciences Holdings (IART) | United States | $2.060B | 10.77 |
| RxSight (RXST) | United States | $2.024B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.257B | 0.00 |
| Artivion (AORT) | United States | $1.233B | 113.23 |
| Pulse Biosciences (PLSE) | United States | $1.110B | 0.00 |
| OPKO Health (OPK) | United States | $1.025B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.963B | 16.37 |
| OrthoPediatrics (KIDS) | United States | $0.749B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.726B | 18.33 |
| Pacific Biosciences Of California (PACB) | United States | $0.722B | 0.00 |
| IRadimed (IRMD) | United States | $0.712B | 38.49 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.702B | 0.00 |
| AxoGen (AXGN) | United States | $0.672B | 0.00 |
| SiBone (SIBN) | United States | $0.669B | 0.00 |
| Paragon 28 (FNA) | United States | $0.605B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.485B | 0.00 |
| CVRx (CVRX) | United States | $0.374B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.369B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.351B | 18.99 |
| Delcath Systems (DCTH) | United States | $0.304B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.301B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.291B | 19.57 |
| Sight Sciences (SGHT) | United States | $0.257B | 0.00 |
| NeuroPace (NPCE) | United States | $0.228B | 0.00 |
| Inogen (INGN) | United States | $0.227B | 0.00 |
| Nevro (NVRO) | United States | $0.216B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.186B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
| 908 Devices (MASS) | United States | $0.136B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.110B | 16.32 |
| EDAP TMS S.A (EDAP) | France | $0.105B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| LENSAR (LNSR) | United States | $0.068B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.061B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.051B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.049B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Envoy Medical (COCH) | United States | $0.038B | 0.00 |
| Neuronetics (STIM) | United States | $0.036B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.028B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.028B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.019B | 0.00 | |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.012B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |